SCHEMBL6510792

SCHEMBL6510792

O=C(NCc1cccc(OCc2cccc(Cl)c2)c1)[C@@H]1CCCN1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 5/20 0.64
HTR2B P41595 3/20 0.64
NPC1 O15118 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
RAB9A P51151 1/20 0.50
KDM4E B2RXH2 1/20 0.50
HDAC3 O15379 3/20 0.49
HDAC1 Q13547 3/20 0.49
HDAC2 Q92769 2/20 0.49
NR4A2 P43354 1/20 0.48
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
GID4 Q8IVV7 1/20 0.46
HTT P42858 1/20 0.45
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6511220 1.00 HTR2C (0.64) HTR2CHTR2BNPC1CYP1A2CYP2D6
SCHEMBL6507511 0.92 HTR2C (0.77) HTR2CHTR2BNPC1RAB9AKDM4E
SCHEMBL7309411 0.89 HTR2C (0.67) HTR2CHTR2BKDM4EHDAC1GID4
SCHEMBL6510388 0.89 HTR2C (0.72) HTR2CHTR2BNPC1RAB9AHDAC3
SCHEMBL6509995 0.88 HTR2C (0.60) HTR2CHTR2BHDAC3HDAC1HDAC2
SCHEMBL6518480 0.88 HTR2C (0.68) HTR2CHTR2BKDM4EHDAC3HDAC1
SCHEMBL15833076 0.85 HTR2C (0.61) HTR2CHTR2BKDM4EHDAC3HDAC1
SCHEMBL21377089 0.84 HTR2C (0.62) HTR2CHTR2BKDM4EHDAC3HDAC1
SCHEMBL6509968 0.84 HTR2C (0.57) HTR2CHTR2BKDM4EHDAC3HDAC1
SCHEMBL15833088 0.84 HTR2C (0.62) HTR2CHTR2BKDM4EHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005040108-A1 PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS NEWRON PHARMACEUTICALS S.P.A. (IT) 2005-05-06 WO claimed
WO-2005040108-A1 PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS NEWRON PHARMACEUTICALS S.P.A. (IT) 2005-05-06 WO disclosed